Evaluation of Medetomidine Alone or in Combination with Tramadol on Tear Secretion in Cats and Their Reversal with Atipamezole

To assess the effect of administration of medetomidine alone or in combination with tramadol on tear secretion (TS) in cats as well as their reversal with atipamezole. For the purpose of the study, a total of 46 cats, representing different breeds and genders, were selected and divided into two groups using a random assignment method. Group M was administered medetomidine at a dose of 80 µg/kg intramuscularly. Group MT was given a combination of medetomidine and tramadol at doses of 80 µg/kg and 2 mg/kg intramuscularly, respectively. Tear secretion was measured using Schirmer tear test I before sedation and at 15 (T15) - 60 (T60) minutes post-sedation with 15 min intervals. At 30 minutes, all cats were given atipamezole (200 µg/kg IM). TS statistically decreased until T30 measurement in both groups (P < 0.05). The TS decreased more in MT group compared to M group at T30 measurements (P < 0.05). TS increased in both groups post-atipamezole but didn't return to initial (T0) levels by study end (T60). Premedication with tear protectors or artificial tears is advised when using MT and M group agents in cats, and atipamezole can reverse their effects post-procedure.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-31
DOI
https://doi.org/10.5281/zenodo.13621468
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Medetomidine Alone or in Combination with Tramadol on Tear Secretion in Cats and Their Reversal with Atipamezole

Zenodo (CERN European Organization for Nuclear Research)
Ubiquitin and proteasome pathways
article

Evaluation of Medetomidine Alone or in Combination with Tramadol on Tear Secretion in Cats and Their Reversal with Atipamezole

article en

Abstract

To assess the effect of administration of medetomidine alone or in combination with tramadol on tear secretion (TS) in cats as well as their reversal with atipamezole. For the purpose of the study, a total of 46 cats, representing different breeds and genders, were selected and divided into two groups using a random assignment method. Group M was administered medetomidine at a dose of 80 µg/kg intramuscularly. Group MT was given a combination of medetomidine and tramadol at doses of 80 µg/kg and 2 mg/kg intramuscularly, respectively. Tear secretion was measured using Schirmer tear test I before sedation and at 15 (T15) - 60 (T60) minutes post-sedation with 15 min intervals. At 30 minutes, all cats were given atipamezole (200 µg/kg IM). TS statistically decreased until T30 measurement in both groups (P < 0.05). The TS decreased more in MT group compared to M group at T30 measurements (P < 0.05). TS increased in both groups post-atipamezole but didn't return to initial (T0) levels by study end (T60). Premedication with tear protectors or artificial tears is advised when using MT and M group agents in cats, and atipamezole can reverse their effects post-procedure.

Zenodo (CERN European Organization for Nuclear Research)
Atatürk University (TR)
Gender equality
Openalex Percentile: Top 64%
Ubiquitin and proteasome pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of Medetomidine Alone or in Combination with Tramadol on Tear Secretion in Cats and Their Reversal with Atipamezole · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS